These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12966780)

  • 1. [Efficacy of bronchodilators: searching for objective criteria].
    Aguilaniu B
    Rev Pneumol Clin; 2003 Apr; 59(2 Pt 2):S11-5. PubMed ID: 12966780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
    [No Abstract]   [Full Text] [Related]  

  • 3. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
    MMW Fortschr Med; 2003 Nov; 145(46):47. PubMed ID: 14699834
    [No Abstract]   [Full Text] [Related]  

  • 4. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
    Calverley P
    MMW Fortschr Med; 2003 Jun; 145(24):20. PubMed ID: 12866294
    [No Abstract]   [Full Text] [Related]  

  • 5. [The MMW Drug Prize 2002: Prize for a new classic with innovation potential].
    Schultze-Werninghaus G
    Med Klin (Munich); 2002 Dec; 97 Suppl 2():1. PubMed ID: 12593173
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COPD treatment by drugs].
    Nafti S
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dyspnea and quality of life in chronic obstructive pulmonary disease].
    Sanjuás C
    Arch Bronconeumol; 2002 Oct; 38(10):485-8. PubMed ID: 12372199
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung function and exercise tolerance after treatment with salmeterol or ipratropium bromide in chronic obstructive pulmonary disease].
    Grzanka A; Pitsch T; Krzywiecki A; Rogala B
    Pol Merkur Lekarski; 2004 Sep; 17(99):208-11. PubMed ID: 15628041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exercise and beta 2-agonists on lung function in chronic obstructive pulmonary disease.
    Corsico A; Fulgoni P; Beccaria M; Zoia MC; Barisione G; Pellegrino R; Brusasco V; Cerveri I
    J Appl Physiol (1985); 2002 Dec; 93(6):2053-8. PubMed ID: 12391117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the combination of two bronchodilators on breathlessness in patients with chronic obstructive pulmonary disease. A crossover clinical trial.
    Sansores R; Ramírez-Vanegas A; Reddy C; Mejía-Alfaro R
    Arch Med Res; 2003; 34(4):292-7. PubMed ID: 12957526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients.
    Santus P; Radovanovic D; Henchi S; Di Marco F; Centanni S; D'Angelo E; Pecchiari M
    Respir Physiol Neurobiol; 2014 Jun; 197():36-45. PubMed ID: 24726342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD.
    Cukier A; Ferreira CA; Stelmach R; Ribeiro M; Cortopassi F; Calverley PM
    Respir Med; 2007 Apr; 101(4):746-53. PubMed ID: 17000096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?
    Baloira A
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):17-24. PubMed ID: 23551020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.